CS logo
small CS logo
Japanese Red Cross Medical Center

Shibuya Ku, Japan
Hospital in Shibuya, Tokyo
4 Chome-1-22 Hiroo, Shibuya City, Tokyo 150-8935

About Japanese Red Cross Medical Center


The Japanese Red Cross Medical Center is a hospital located in Hiroo, Shibuya-ku, Tokyo. It is the central medical center of the Japanese Red Cross Society, and is directly controlled by it. The site of Hiroo, Tokyo, where the medical center is currently located, was where a mansion of Horita Binakamori once stood.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Japanese Red Cross Medical Center


During the past decade, Japanese Red Cross Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Medical Center" #1 collaborator was "Japan Lung Cancer Society" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Japanese Red Cross Medical Center


According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Medical Center" are "Multiple Myeloma" (2 trials), "Extensive Disease Small Cell Lung Cancer" (1 trials), "Multiple Myeloma (MM)" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Japanese Red Cross Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Japanese Red Cross Medical Center


Most popular intervention types in "Japanese Red Cross Medical Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Teclistamab" (2 trials), "Bortezomib" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Japanese Red Cross Medical Center


The vast majority of trials in "Japanese Red Cross Medical Center" are 4 trials for "All" genders.

Clinical Trials Status at Japanese Red Cross Medical Center


Currently, there are NaN active trials in "Japanese Red Cross Medical Center". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Japanese Red Cross Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Japanese Red Cross Medical Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".